iLoF

📍 Oxford, United Kingdom👥 34 employees💰 Last funded Feb 2022
Biotechnology Research🌐 ilof.tech
Website LinkedIn
iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported by leading institutions like Microsoft Ventures, Mayfield or the Oxford University, and has been regularly featured by outlets like Tech Crunch, Wired, or Sifted as a rising star in AI-Driven Drug Discovery, Health Screening & Data Analytics.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Croatia
1
Frequently asked questions
Who invested in iLoF?
iLoF has 1 investors on record on gritt.io.
When did iLoF last raise funding?
The most recent investment in iLoF recorded on gritt.io was in February 2022.
What industry is iLoF in?
iLoF operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is iLoF based?
iLoF is headquartered in Oxford, United Kingdom.